Correlation Between Zomedica Pharmaceuticals and Tilray

Can any of the company-specific risk be diversified away by investing in both Zomedica Pharmaceuticals and Tilray at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zomedica Pharmaceuticals and Tilray into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zomedica Pharmaceuticals Corp and Tilray Inc, you can compare the effects of market volatilities on Zomedica Pharmaceuticals and Tilray and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zomedica Pharmaceuticals with a short position of Tilray. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zomedica Pharmaceuticals and Tilray.

Diversification Opportunities for Zomedica Pharmaceuticals and Tilray

-0.18

Correlation Coefficient

Zomedica Pharmaceuticals  Tilray

Good diversification

The 3 months correlation between Zomedica and Tilray is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Zomedica Pharmaceuticals Corp and Tilray Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tilray Inc and Zomedica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zomedica Pharmaceuticals Corp are associated (or correlated) with Tilray. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tilray Inc has no effect on the direction of Zomedica Pharmaceuticals i.e., Zomedica Pharmaceuticals and Tilray go up and down completely randomly.

Pair Corralation between Zomedica Pharmaceuticals and Tilray

Considering the 90-day investment horizon Zomedica Pharmaceuticals Corp is expected to generate 1.22 times more return on investment than Tilray. However, Zomedica Pharmaceuticals is 1.22 times more volatile than Tilray Inc. It trades about 0.02 of its potential returns per unit of risk. Tilray Inc is currently generating about -0.11 per unit of risk. If you would invest  13.00  in Zomedica Pharmaceuticals Corp on September 5, 2024 and sell it today you would earn a total of  0.00  from holding Zomedica Pharmaceuticals Corp or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Zomedica Pharmaceuticals Corp  vs.  Tilray Inc

Zomedica Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Zomedica Pharmaceuticals Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Zomedica Pharmaceuticals is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Tilray Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tilray Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Zomedica Pharmaceuticals and Tilray

The main advantage of trading using opposite Zomedica Pharmaceuticals and Tilray positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zomedica Pharmaceuticals position performs unexpectedly, Tilray can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tilray will offset losses from the drop in Tilray's long position.

The idea behind Zomedica Pharmaceuticals Corp and Tilray Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.